Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Mazzoran, L; Zorat, F; Chemello, L; Croce, LS; Rigato, I; Cavalletto, L; Bernardinello, E; Tiribelli, C; Alberti, A; Pozzato, G
   Human leucocyte interferon-alpha in the treatment of chronic hepatitis C
   DIGESTIVE AND LIVER DISEASE
   
   L. Mazzoran et al., "Human leucocyte interferon-alpha in the treatment of chronic hepatitis C", DIG LIVER D, 33(4), 2001, pp. 347-352
2. Valentini, P; Mariotti, P; Ngalikpima, CJ; Angelone, DF; Ranno, O
   Seizures in an interferon-treated child
   DIGESTIVE AND LIVER DISEASE
   
   P. Valentini et al., "Seizures in an interferon-treated child", DIG LIVER D, 33(4), 2001, pp. 363-365
3. Yoshida, EM; Buczkowski, AK; Giulivi, A; Zou, SM; Forrester, LA
   A cross-sectional study of SEN virus in liver transplant recipients
   LIVER TRANSPLANTATION
   
   E.M. Yoshida et al., "A cross-sectional study of SEN virus in liver transplant recipients", LIVER TRANS, 7(6), 2001, pp. 521-525
4. Jonsson, JR; Hong, C; Purdie, DM; Hawley, C; Isbel, N; Butler, M; Balderson, GA; Clouston, D; Pandeya, N; Stuart, K; Edwards-Smith, C; Crawford, DH; Fawcett, J; Powell, EE
   Role of cytokine gene polymorphisms in acute rejection and renal impairment after liver transplantation
   LIVER TRANSPLANTATION
   
   J.R. Jonsson et al., "Role of cytokine gene polymorphisms in acute rejection and renal impairment after liver transplantation", LIVER TRANS, 7(3), 2001, pp. 255-263
5. Rewald, E; Francischetti, MM; Nydegger, UE
   IVIG-pools: regulatory gifts - Transiting from harmony toward harmonious immunoglobulins: Why? and why not?
   TRANSFUSION AND APHERESIS SCIENCE
   
   E. Rewald et al., "IVIG-pools: regulatory gifts - Transiting from harmony toward harmonious immunoglobulins: Why? and why not?", TRANSF AP S, 25(2), 2001, pp. 113-137
6. Thelu, MA; Baud, M; Leroy, V; Seigneurin, JM; Zarski, JP
   Dynamics of viral quasispecies during interferon therapy in non responder chronic hepatitis C patients
   JOURNAL OF CLINICAL VIROLOGY
   
   M.A. Thelu et al., "Dynamics of viral quasispecies during interferon therapy in non responder chronic hepatitis C patients", J CLIN VIRO, 22(1), 2001, pp. 125-131
7. Haushofer, AC; Kopty, C; Hauer, R; Brunner, H; Halbmayer, WM
   HCV genotypes and age distribution in patients of Vienna and surrounding areas
   JOURNAL OF CLINICAL VIROLOGY
   
   A.C. Haushofer et al., "HCV genotypes and age distribution in patients of Vienna and surrounding areas", J CLIN VIRO, 20(1-2), 2001, pp. 41-47
8. Moriyama, M; Zhao, ZY; Wu, LR; Wang, XQ; Ohshiro, S; Iwasaki, H; Ichijima, S; Iwaguchi, K; Matsumura, H; Sugitani, M; Komiyama, K; Arakawa, Y
   Clinico-epidemiological study of GBV-C/HGV infection in Tokyo metropolitan, and Nanjing and Yanbian cities in the People's Republic of China
   HEPATOLOGY RESEARCH
   
   M. Moriyama et al., "Clinico-epidemiological study of GBV-C/HGV infection in Tokyo metropolitan, and Nanjing and Yanbian cities in the People's Republic of China", HEPATOL RES, 21(3), 2001, pp. 268-279
9. Arase, Y; Chayama, K; Ikeda, K; Tsubota, A; Suzuki, Y; Saitoh, S; Kobayashi, M; Suzuki, F; Akuta, N; Someya, T; Kobayashi, M; Kumada, H
   Randomized controlled clinical trial of lymphoblastoid interferon-alpha for chronic hepatitis C
   HEPATOLOGY RESEARCH
   
   Y. Arase et al., "Randomized controlled clinical trial of lymphoblastoid interferon-alpha for chronic hepatitis C", HEPATOL RES, 21(1), 2001, pp. 55-66
10. Murawaki, Y; Ikuta, Y; Koda, M; Kawasaki, H
    Comparison of clinical laboratory liver tests between asymptomatic HBV andHCV carriers with persistently normal aminotransferase serum levels
    HEPATOLOGY RESEARCH
    
    Y. Murawaki et al., "Comparison of clinical laboratory liver tests between asymptomatic HBV andHCV carriers with persistently normal aminotransferase serum levels", HEPATOL RES, 21(1), 2001, pp. 67-75
11. Suou, T; Mitsuda, A; Koda, M; Matsuda, H; Maruyama, S; Tanaka, H; Kishimoto, Y; Michimori, K; Hirooka, Y; Kawasaki, H
    Interferon alpha inhibits intrahepatic recurrence in hepatocellular carcinoma with chronic hepatitis C: a pilot study
    HEPATOLOGY RESEARCH
    
    T. Suou et al., "Interferon alpha inhibits intrahepatic recurrence in hepatocellular carcinoma with chronic hepatitis C: a pilot study", HEPATOL RES, 20(3), 2001, pp. 301-311
12. Okanoue, T; Daimon, Y; Kirishima, T; Ohnishi, N; Nakamura, H; Nagao, Y; Minami, M; Itoh, Y
    Retreatment with interferon-alpha at dosages or period increased by 1.3 times is effective for treatment for transient responders and non-responders in chronic hepatitis C patients
    HEPATOLOGY RESEARCH
    
    T. Okanoue et al., "Retreatment with interferon-alpha at dosages or period increased by 1.3 times is effective for treatment for transient responders and non-responders in chronic hepatitis C patients", HEPATOL RES, 20(3), 2001, pp. 348-358
13. Bacosi, M; Patsouri, M; Miglioresi, L; Patrizi, F; Russo, F; Ricci, GL
    Combined treatment of HCV infection: is there a need for meta-analysis?
    HEPATOLOGY RESEARCH
    
    M. Bacosi et al., "Combined treatment of HCV infection: is there a need for meta-analysis?", HEPATOL RES, 20(3), 2001, pp. 359-371
14. Chu, CW; Hwang, SJ; Luo, JC; Wang, YJ; Lu, RH; Lai, CR; Tsay, SH; Li, CP; Wu, JC; Chang, FY; Lee, SD
    Clinical, virological, immunological, and pathological significance of GB virus C/hepatitis G infection in patients with chronic hepatitis C
    HEPATOLOGY RESEARCH
    
    C.W. Chu et al., "Clinical, virological, immunological, and pathological significance of GB virus C/hepatitis G infection in patients with chronic hepatitis C", HEPATOL RES, 19(3), 2001, pp. 225-236
15. Omagari, K; Matsuo, I; Ohba, K; Masuda, J; Hazama, H; Sakimura, K; Kinoshita, H; Tsurutani, H; Isomoto, H; Murase, K; Kohno, S
    Synchronized disappearance of serum HCV-RNA, anti-U1 RNP, anti-La/SS-B, and anti-Scl-70 in a patient with chronic hepatitis
    HEPATOLOGY RESEARCH
    
    K. Omagari et al., "Synchronized disappearance of serum HCV-RNA, anti-U1 RNP, anti-La/SS-B, and anti-Scl-70 in a patient with chronic hepatitis", HEPATOL RES, 19(3), 2001, pp. 263-269
16. Hwang, SJ; Lee, SD; Chu, CW; Lu, RH; Chang, FY
    An open-label trial of consensus interferon 15 mu g in the treatment of Chinese patients with chronic hepatitis C
    HEPATOLOGY RESEARCH
    
    S.J. Hwang et al., "An open-label trial of consensus interferon 15 mu g in the treatment of Chinese patients with chronic hepatitis C", HEPATOL RES, 19(3), 2001, pp. 284-293
17. Yagura, M; Murai, S; Kojima, H; Tokita, H; Kamitsukasa, H; Harada, H
    Does the control of alanine aminotransferase levels lead to a regression of liver fibrosis in chronic hepatitis C patients?
    HEPATOLOGY RESEARCH
    
    M. Yagura et al., "Does the control of alanine aminotransferase levels lead to a regression of liver fibrosis in chronic hepatitis C patients?", HEPATOL RES, 19(2), 2001, pp. 144-157
18. Arase, Y; Ikeda, K; Chayama, K; Murashima, N; Tsubota, A; Suzuki, Y; Saitoh, S; Kobayashi, M; Kobayashi, M; Suzuki, F; Kumada, H
    Efficacy of IFN therapy based on duration period of negative HCV-RNA during IFN administration
    HEPATOLOGY RESEARCH
    
    Y. Arase et al., "Efficacy of IFN therapy based on duration period of negative HCV-RNA during IFN administration", HEPATOL RES, 19(1), 2001, pp. 22-30
19. Teuber, G; Berg, T; Naumann, U; Raedle, J; Brinkmann, S; Hopf, U; Zeuzem, S
    Randomized, placebo-controlled, double-blind trial with interferon-alpha with and without amantadine sulphate in primary interferon-alpha nonresponders with chronic hepatitis C
    JOURNAL OF VIRAL HEPATITIS
    
    G. Teuber et al., "Randomized, placebo-controlled, double-blind trial with interferon-alpha with and without amantadine sulphate in primary interferon-alpha nonresponders with chronic hepatitis C", J VIRAL HEP, 8(4), 2001, pp. 276-283
20. Gaeta, GB; Stornaiuolo, G; Stanzione, M; Ascione, T; Pasquazzi, C; Taliani, G; Cimino, L; Budillon, G; Piccinino, F
    Interferon-alpha plus amantadine in chronic hepatitis C resistant to interferon alone: a pilot randomized study
    JOURNAL OF VIRAL HEPATITIS
    
    G.B. Gaeta et al., "Interferon-alpha plus amantadine in chronic hepatitis C resistant to interferon alone: a pilot randomized study", J VIRAL HEP, 8(4), 2001, pp. 284-286
21. Hu, KQ; Vierling, JM; Redeker, AG
    Viral, host and interferon-related factors modulating the effect of interferon therapy for hepatitis C virus infection
    JOURNAL OF VIRAL HEPATITIS
    
    K.Q. Hu et al., "Viral, host and interferon-related factors modulating the effect of interferon therapy for hepatitis C virus infection", J VIRAL HEP, 8(1), 2001, pp. 1-18
22. Thevenot, T; Regimbeau, C; Ratziu, V; Leroy, V; Opolon, P; Poynard, T
    Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 Update
    JOURNAL OF VIRAL HEPATITIS
    
    T. Thevenot et al., "Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 Update", J VIRAL HEP, 8(1), 2001, pp. 48-62
23. Chan, ATC; Jacobs, P; Yeo, W; Lai, M; Hazlett, CB; Mok, TSK; Leung, TWT; Lau, WY; Johnson, PJ
    The cost of palliative care for hepatocellular carcinoma in Hong Kong
    PHARMACOECONOMICS
    
    A.T.C. Chan et al., "The cost of palliative care for hepatocellular carcinoma in Hong Kong", PHARMACOECO, 19(9), 2001, pp. 947-953
24. Diago, M; Lujan, M; Valeros, D; Tuset, C; Marcaida, G; Garcia, V; Cors, R; Carbonell, P
    Long-term response to interferon plus ribavirin in patients with chronic hepatitis C refractory to interferon
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
    
    M. Diago et al., "Long-term response to interferon plus ribavirin in patients with chronic hepatitis C refractory to interferon", REV ESP E D, 93(6), 2001, pp. 359-363
25. Fillon, S; Warntges, S; Matskevitch, J; Moschen, I; Setiawan, I; Gamper, N; Feng, YX; Stegen, C; Friedrich, B; Waldegger, S; Broer, S; Wagner, CA; Huber, SM; Klingel, K; Vereninov, A; Lang, F
    Serum- and glucocorticoid-dependent kinase, cell volume, and the regulation of epithelial transport
    COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-MOLECULAR AND INTEGRATIVE PHYSIOLOGY
    
    S. Fillon et al., "Serum- and glucocorticoid-dependent kinase, cell volume, and the regulation of epithelial transport", COMP BIOC A, 130(3), 2001, pp. 367-376
26. Yanai, Y; Sanou, O; Kayano, T; Ariyasu, H; Yamamoto, K; Yamauchi, H; Ikegami, H; Kurimoto, M
    Analysis of the antiviral activities of natural IFN-alpha preparations andtheir subtype compositions
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    
    Y. Yanai et al., "Analysis of the antiviral activities of natural IFN-alpha preparations andtheir subtype compositions", J INTERF CY, 21(10), 2001, pp. 835-841
27. Agrati, C; D'Offizi, G; Narciso, P; Abrignani, S; Ippolito, G; Colizzi, V; Poccia, F
    V delta 1T lymphocytes expressing a Th1 phenotype are the major gamma delta T cell subset infiltrating the liver of HCV-infected persons
    MOLECULAR MEDICINE
    
    C. Agrati et al., "V delta 1T lymphocytes expressing a Th1 phenotype are the major gamma delta T cell subset infiltrating the liver of HCV-infected persons", MOL MED, 7(1), 2001, pp. 11-19
28. Malek-Ahmadi, P
    Mood disorders associated with interferon treatment: Theoretical and practical considerations
    ANNALS OF PHARMACOTHERAPY
    
    P. Malek-Ahmadi, "Mood disorders associated with interferon treatment: Theoretical and practical considerations", ANN PHARMAC, 35(4), 2001, pp. 489-495
29. Whitfield, JB
    Gamma glutamyl transferase
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
    
    J.B. Whitfield, "Gamma glutamyl transferase", CR R CL LAB, 38(4), 2001, pp. 263-355
30. Lee, YS; Yoon, SK; Chung, ES; Bae, SH; Choi, JY; Han, JY; Chung, KW; Sun, HS; Kim, BS; Kim, BK
    The relationship of histologic activity to serum ALT, HCV genotype and HCVRNA titers in chronic hepatitis C
    JOURNAL OF KOREAN MEDICAL SCIENCE
    
    Y.S. Lee et al., "The relationship of histologic activity to serum ALT, HCV genotype and HCVRNA titers in chronic hepatitis C", J KOR MED S, 16(5), 2001, pp. 585-591
31. Zhang, XL; Quan, QZ; Sun, ZQ; Wang, YJ; Jiang, XL; Wang, D; Li, WB
    Protective effects of cyclosporine A on T-cell dependent ConA-induced liver injury in Kunming mice
    WORLD JOURNAL OF GASTROENTEROLOGY
    
    X.L. Zhang et al., "Protective effects of cyclosporine A on T-cell dependent ConA-induced liver injury in Kunming mice", WORLD J GAS, 7(4), 2001, pp. 569-571
32. Beurton, I; Bertrand, MA; Bresson-Hadni, S; Parquet-Gernez, A; Goudemand, J; Paris, JC; Cales, P; Briquel, ME; Gaucher, P; Cortey, ML; Trepo, C; Miguet, JP; Cahn, JY
    Interferon alpha therapy in haemophilic patients with chronic hepatitis C:a French multicentre pilot study of 58 patients
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    
    I. Beurton et al., "Interferon alpha therapy in haemophilic patients with chronic hepatitis C:a French multicentre pilot study of 58 patients", EUR J GASTR, 13(7), 2001, pp. 859-864
33. Asselah, T; Condat, B; Cazals-Hatem, D; Hassani, Z; Bernuau, J; Groussard, O; Mussot, S; Leseche, G; Marcellin, P; Erlinger, S; Valla, D
    Ectopic hepatocellular carcinoma arising in the left chest wall: a long-term follow-up
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    
    T. Asselah et al., "Ectopic hepatocellular carcinoma arising in the left chest wall: a long-term follow-up", EUR J GASTR, 13(7), 2001, pp. 873-875
34. Ferenci, P; Stauber, R; Steindl-Munda, P; Gschwantler, M; Fickert, P; Datz, C; Muller, C; Hackl, F; Rainer, W; Watkins-Riedel, T; Lin, W; Krejs, GJ; Gangl, A
    Treatment of patients with chronic hepatitis C not responding to interferon with high-dose interferon alpha with or without ribavirin: final results of a prospective randomized trial
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    
    P. Ferenci et al., "Treatment of patients with chronic hepatitis C not responding to interferon with high-dose interferon alpha with or without ribavirin: final results of a prospective randomized trial", EUR J GASTR, 13(6), 2001, pp. 699-705
35. Werling, K; Szentirmay, Z; Szepesi, A; Schaff, Z; Szalay, F; Szabo, Z; Telegdy, L; David, K; Stotz, G; Tulassay, Z
    Hepatocyte proliferation and cell cycle phase fractions in chronic viral hepatitis C by image analysis method
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    
    K. Werling et al., "Hepatocyte proliferation and cell cycle phase fractions in chronic viral hepatitis C by image analysis method", EUR J GASTR, 13(5), 2001, pp. 489-493
36. Giannini, E; Caglieris, S; Ceppa, P; Risso, D; Lantieri, PB; Testa, R
    Serum pro-collagen III peptide levels are related to lobular necrosis in untreated patients with chronic hepatitis C
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    
    E. Giannini et al., "Serum pro-collagen III peptide levels are related to lobular necrosis in untreated patients with chronic hepatitis C", EUR J GASTR, 13(2), 2001, pp. 137-141
37. Queneau, PE; Osaer, F; Bronowicki, JP; Monnot, B; Thiefin, G; Bettinger, D; Carbillet, JP; Raabe, JJ; Fratte, S; Minello-Franza, A; Bresson-Hadni, S; Miguet, JP
    Treatment of mild chronic hepatitis C with interferon alpha-2b: results ofa multi-centre randomized study in 80 patients
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    
    P.E. Queneau et al., "Treatment of mild chronic hepatitis C with interferon alpha-2b: results ofa multi-centre randomized study in 80 patients", EUR J GASTR, 13(2), 2001, pp. 143-147
38. Huber, R; Ludtke, R; Klassen, M; Muller-Buscher, G; Wolff-Vorbeck, G; Scheer, R
    Effects of a mistletoe preparation with defined lectin content on chronic hepatitis C: An individually controlled cohort study
    EUROPEAN JOURNAL OF MEDICAL RESEARCH
    
    R. Huber et al., "Effects of a mistletoe preparation with defined lectin content on chronic hepatitis C: An individually controlled cohort study", EUR J MED R, 6(9), 2001, pp. 399-405
39. Desch, S; Vaeth, T; Tamba, M; Klinker, H; Langmann, P
    Efficacy and safety of an initial daily dosing regimen of interferon-alpha-2A in treatment-naive patients with chronic hepatitis C and HCV genotype 1
    EUROPEAN JOURNAL OF MEDICAL RESEARCH
    
    S. Desch et al., "Efficacy and safety of an initial daily dosing regimen of interferon-alpha-2A in treatment-naive patients with chronic hepatitis C and HCV genotype 1", EUR J MED R, 6(6), 2001, pp. 242-246
40. Tossing, G
    New developments in interferon therapy
    EUROPEAN JOURNAL OF MEDICAL RESEARCH
    
    G. Tossing, "New developments in interferon therapy", EUR J MED R, 6(2), 2001, pp. 47-65
41. Malaguarnera, M; Di Fazio, I; Trovato, BA; Pistone, G; Mazzoleni, G
    Alpha-interferon (IFN-alpha) treatment of chronic hepatitis C: analysis ofsome predictive factors for the response
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    
    M. Malaguarnera et al., "Alpha-interferon (IFN-alpha) treatment of chronic hepatitis C: analysis ofsome predictive factors for the response", INT J CL PH, 39(6), 2001, pp. 239-245
42. Nishiguchi, S; Shiomi, S; Enomoto, M; Lee, C; Jomura, H; Tamori, A; Habu, D; Takeda, T; Yanagihara, N; Shiraki, K
    Does ascorbic acid prevent retinopathy during interferon therapy in patients with chronic hepatitis C?
    JOURNAL OF GASTROENTEROLOGY
    
    S. Nishiguchi et al., "Does ascorbic acid prevent retinopathy during interferon therapy in patients with chronic hepatitis C?", J GASTRO, 36(7), 2001, pp. 486-491
43. Hwang, SJ; Luo, JC; Chu, CW; Lai, CR; Tsay, SH; Chang, FY; Lee, SD
    Clinical, virological, and pathological significance of hepatic bile duct injuries in Chinese patients with chronic hepatitis C
    JOURNAL OF GASTROENTEROLOGY
    
    S.J. Hwang et al., "Clinical, virological, and pathological significance of hepatic bile duct injuries in Chinese patients with chronic hepatitis C", J GASTRO, 36(6), 2001, pp. 392-398
44. Murawaki, Y; Ikuta, Y; Okamoto, K; Koda, M; Kawasaki, H
    Diagnostic value of serum markers of connective tissue turnover for predicting histological staging and grading in patients with chronic hepatitis C
    JOURNAL OF GASTROENTEROLOGY
    
    Y. Murawaki et al., "Diagnostic value of serum markers of connective tissue turnover for predicting histological staging and grading in patients with chronic hepatitis C", J GASTRO, 36(6), 2001, pp. 399-406
45. Yagura, M; Harada, H
    Treatment of chronic hepatitis C patients with amantadine
    JOURNAL OF GASTROENTEROLOGY
    
    M. Yagura e H. Harada, "Treatment of chronic hepatitis C patients with amantadine", J GASTRO, 36(11), 2001, pp. 759-763
46. Magee, CC
    Renal thrombotic microangiopathy induced by interferon-alpha
    NEPHROLOGY DIALYSIS TRANSPLANTATION
    
    C.C. Magee, "Renal thrombotic microangiopathy induced by interferon-alpha", NEPH DIAL T, 16(10), 2001, pp. 2111-2112
47. Kao, JH; Lai, MY; Chen, PJ; Cheng, YM; Chen, DS
    Prolonged interferon treatment after combination interferon and ribavirin therapy in patients with chronic hepatitis C: A clinical trial of interferon relapsers and non-responders
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
    
    J.H. Kao et al., "Prolonged interferon treatment after combination interferon and ribavirin therapy in patients with chronic hepatitis C: A clinical trial of interferon relapsers and non-responders", J FORMOS ME, 100(10), 2001, pp. 662-667
48. Par, A; Telegdy, L; Dalmi, L; Muller, E
    Therapy for chronic hepatitis C
    JOURNAL OF PHYSIOLOGY-PARIS
    
    A. Par et al., "Therapy for chronic hepatitis C", J PHYSL-PAR, 95(1-6), 2001, pp. 399-405
49. Hussain, SA; Ferry, DR; El-Gazzaz, G; Mirza, DF; James, ND; McMaster, P; Kerr, DJ
    Hepatocellular carcinoma
    ANNALS OF ONCOLOGY
    
    S.A. Hussain et al., "Hepatocellular carcinoma", ANN ONCOL, 12(2), 2001, pp. 161-172
50. Shiono, Y; Ikeda, R; Hayashi, H; Wakusawa, S; Sanae, F; Takikawa, T; Imaizumi, Y; Yano, M; Yoshioka, K; Kawanaka, M; Yamada, G
    C282Y and H63D mutations in the HFE gene have no effect on iron overload disorders in Japan
    INTERNAL MEDICINE
    
    Y. Shiono et al., "C282Y and H63D mutations in the HFE gene have no effect on iron overload disorders in Japan", INTERN MED, 40(9), 2001, pp. 852-856
51. Hayashi, N
    Topics of type C chronic liver disease
    INTERNAL MEDICINE
    
    N. Hayashi, "Topics of type C chronic liver disease", INTERN MED, 40(2), 2001, pp. 180-181
52. Kitazawa, E; Igarashi, T; Kawaguchi, N; Matsushima, H; Kawashima, Y; Hankins, RW; Miyakawa, H
    Differences in anti-LKM-1 autoantibody immunoreactivity to CYP2D6 antigenic sites between hepatitis C virus-negative and -positive patients
    JOURNAL OF AUTOIMMUNITY
    
    E. Kitazawa et al., "Differences in anti-LKM-1 autoantibody immunoreactivity to CYP2D6 antigenic sites between hepatitis C virus-negative and -positive patients", J AUTOIMMUN, 17(3), 2001, pp. 243-249
53. Unal, G; de Boer, JB; Borsboom, GJJM; Brouwer, JT; Essink-Bot, ML; de Man, RA
    A psychometric comparison of health-related quality of life measures in chronic liver disease
    JOURNAL OF CLINICAL EPIDEMIOLOGY
    
    G. Unal et al., "A psychometric comparison of health-related quality of life measures in chronic liver disease", J CLIN EPID, 54(6), 2001, pp. 587-596
54. Maes, M; Capuron, L; Ravaud, A; Gualde, N; Bosmans, E; Egyed, B; Dantzer, R; Neveu, PJ
    Lowered serum dipeptidyl peptidase IV activity is associated with depressive symptoms and cytokine production in cancer patients receiving interleukin-2-based immunotherapy
    NEUROPSYCHOPHARMACOLOGY
    
    M. Maes et al., "Lowered serum dipeptidyl peptidase IV activity is associated with depressive symptoms and cytokine production in cancer patients receiving interleukin-2-based immunotherapy", NEUROPSYCH, 24(2), 2001, pp. 130-140
55. Regev, A; Schiff, ER
    Liver disease in the elderly
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA
    
    A. Regev e E.R. Schiff, "Liver disease in the elderly", GASTRO CLIN, 30(2), 2001, pp. 547
56. Huang, XX; Yamashiki, M; Nakatani, K; Nobori, T; Mase, A
    Semi-quantitative analysis of cytokine mRNA expression induced by the herbal medicine Sho-saiko-to (TJ-9) using a Gel Doc system
    JOURNAL OF CLINICAL LABORATORY ANALYSIS
    
    X.X. Huang et al., "Semi-quantitative analysis of cytokine mRNA expression induced by the herbal medicine Sho-saiko-to (TJ-9) using a Gel Doc system", J CL LAB AN, 15(4), 2001, pp. 199-209
57. Kraus, I; Vitezic, D
    Acute hepatitis induced by alpha-interferon in a patient with chronic hepatitis C
    CANADIAN JOURNAL OF GASTROENTEROLOGY
    
    I. Kraus e D. Vitezic, "Acute hepatitis induced by alpha-interferon in a patient with chronic hepatitis C", CAN J GASTR, 15(5), 2001, pp. 333-335
58. Tilg, H
    Cytokines and liver diseases
    CANADIAN JOURNAL OF GASTROENTEROLOGY
    
    H. Tilg, "Cytokines and liver diseases", CAN J GASTR, 15(10), 2001, pp. 661-668
59. Hwang, SJ; Luo, JC; Chu, CW; Lai, CR; Lu, CL; Tsay, SH; Wu, JC; Chang, FY; Lee, SD
    Hepatic steatosis in chronic hepatitis C virus infection: Prevalence and clinical correlation
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
    
    S.J. Hwang et al., "Hepatic steatosis in chronic hepatitis C virus infection: Prevalence and clinical correlation", J GASTR HEP, 16(2), 2001, pp. 190-195
60. Shimizu, I; Omoya, T; Takaoka, T; Wada, S; Wada, H; Taoka, M; Hayashi, H; Hayashi, S; Honda, H; Sano, N; Ito, S
    Serum amino-terminal propeptide of type III procollagen and 7S domain of type IV collagen correlate with hepatic iron concentration in patients with chronic hepatitis C following alpha-interferon therapy
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
    
    I. Shimizu et al., "Serum amino-terminal propeptide of type III procollagen and 7S domain of type IV collagen correlate with hepatic iron concentration in patients with chronic hepatitis C following alpha-interferon therapy", J GASTR HEP, 16(2), 2001, pp. 196-201
61. Kumar, D; Tandon, RK
    Use of ursodeoxycholic acid in liver diseases
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
    
    D. Kumar e R.K. Tandon, "Use of ursodeoxycholic acid in liver diseases", J GASTR HEP, 16(1), 2001, pp. 3-14
62. Charron, A; Bessis, D; Dereure, O; Guilhou, JJ; Guillot, B
    Skin reactions to topical interferons
    PRESSE MEDICALE
    
    A. Charron et al., "Skin reactions to topical interferons", PRESSE MED, 30(31), 2001, pp. 1555-1560
63. Emerit, J; Beaumont, C; Trivin, F
    Iron metabolism, free radicals, and oxidative injury
    BIOMEDICINE & PHARMACOTHERAPY
    
    J. Emerit et al., "Iron metabolism, free radicals, and oxidative injury", BIOMED PHAR, 55(6), 2001, pp. 333-339
64. Recasens, M; Aguilera, E; Ampurdanes, S; Tapias, JMS; Simo, O; Casamitjana, R; Conget, I
    Abrupt onset of diabetes during interferon-alpha therapy in patients with chronic hepatitis C
    DIABETIC MEDICINE
    
    M. Recasens et al., "Abrupt onset of diabetes during interferon-alpha therapy in patients with chronic hepatitis C", DIABET MED, 18(9), 2001, pp. 764-767
65. Hjelmstrom, P
    Lymphoid neogenesis: de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines
    JOURNAL OF LEUKOCYTE BIOLOGY
    
    P. Hjelmstrom, "Lymphoid neogenesis: de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines", J LEUK BIOL, 69(3), 2001, pp. 331-339
66. Gibson, LE
    Cutaneous vasculitis update
    DERMATOLOGIC CLINICS
    
    L.E. Gibson, "Cutaneous vasculitis update", DERM CLIN, 19(4), 2001, pp. 603
67. Bacq, Y
    Synosis: Hepatopathy during pregnancy
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
    
    Y. Bacq, "Synosis: Hepatopathy during pregnancy", GASTRO CL B, 25(8-9), 2001, pp. 791-798
68. Pariente, A; Cadranel, JF; Blanchi, A; Bories, C; Bour, B; Cassan, P; Causse, X; Cadranel, JF; Denis, J; Druart, F; Gerbal, JL; Goldfain, D; Ink, O; Lafon, J; Lesgourgues, B; Moindro, H; Morin, T; Nalet, B; Pariente, A; Picon, M; Renou, C; Schouler-Roux, L; Staub, JL
    Who dies with hepatitis C virus in France?
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
    
    A. Pariente et al., "Who dies with hepatitis C virus in France?", GASTRO CL B, 25(4), 2001, pp. 347-352
69. Reinhold-Keller, E; Lamprecht, P; Feller, AC; Gross, WL
    Polyarthritis following interferon alpha treatment in a patient with localized Wegener's granulomatosis
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    
    E. Reinhold-Keller et al., "Polyarthritis following interferon alpha treatment in a patient with localized Wegener's granulomatosis", CLIN EXP RH, 19(2), 2001, pp. 227-228
70. Fabrizi, F; Lunghi, G; Martin, P
    Treatment of HCV-related liver disease in the dialysis population: A novelchallenge for clinical nephrologists
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
    
    F. Fabrizi et al., "Treatment of HCV-related liver disease in the dialysis population: A novelchallenge for clinical nephrologists", INT J ARTIF, 24(6), 2001, pp. 335-346
71. Nicholl, DS; Daniels, HM; Thabrew, MI; Grayer, RJ; Simmonds, MSJ; Hughes, RD
    In vitro studies on the immunomodulatory effects of extracts of Osbeckia aspera
    JOURNAL OF ETHNOPHARMACOLOGY
    
    D.S. Nicholl et al., "In vitro studies on the immunomodulatory effects of extracts of Osbeckia aspera", J ETHNOPHAR, 78(1), 2001, pp. 39-44
72. Ravenel, JG; McAdams, HP; Plankeel, JF; Butnor, KJ; Sporn, TA
    Sarcoidosis induced by interferon therapy
    AMERICAN JOURNAL OF ROENTGENOLOGY
    
    J.G. Ravenel et al., "Sarcoidosis induced by interferon therapy", AM J ROENTG, 177(1), 2001, pp. 199-201
73. Ploeger, B; Mensinga, T; Sips, A; Seinen, W; Meulenbelt, J; DeJongh, J
    The pharmacokinetics of glycyrrhizic acid evaluated by physiologically based pharmacokinetic modeling
    DRUG METABOLISM REVIEWS
    
    B. Ploeger et al., "The pharmacokinetics of glycyrrhizic acid evaluated by physiologically based pharmacokinetic modeling", DRUG METAB, 33(2), 2001, pp. 125-147
74. Harris, JM; Martin, NE; Modi, M
    Pegylation - A novel process for modifying pharmacokinetics
    CLINICAL PHARMACOKINETICS
    
    J.M. Harris et al., "Pegylation - A novel process for modifying pharmacokinetics", CLIN PHARMA, 40(7), 2001, pp. 539-551
75. Daly, AK; Day, CP
    Candidate gene case-control association studies: advantages and potential pitfalls
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    
    A.K. Daly e C.P. Day, "Candidate gene case-control association studies: advantages and potential pitfalls", BR J CL PH, 52(5), 2001, pp. 489-499
76. Torre, F; Campo, N; Giusto, R; Ansaldi, F; Icardi, GC; Picciotto, A
    Antiviral activity of amantadine in elderly patients with chronic hepatitis C
    GERONTOLOGY
    
    F. Torre et al., "Antiviral activity of amantadine in elderly patients with chronic hepatitis C", GERONTOLOGY, 47(6), 2001, pp. 330-333
77. Sereno, S; Toccaceli, F; Russo, V; Iacomi, F; Zardi, EM; Laghi, V
    Doppler sonography measurement of portal blood flow velocity after glucagon injection in patients with chronic HCV infection
    ULTRASOUND IN MEDICINE AND BIOLOGY
    
    S. Sereno et al., "Doppler sonography measurement of portal blood flow velocity after glucagon injection in patients with chronic HCV infection", ULTRASOUN M, 27(5), 2001, pp. 723-726
78. Olivieri, I; Padula, A; Ciancio, G; La Civita, L
    Psoriatic arthritis and alpha-interferon
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
    
    I. Olivieri et al., "Psoriatic arthritis and alpha-interferon", SC J RHEUM, 30(3), 2001, pp. 175-175
79. Ikeuchi, T; Yokosuka, O; Kanda, T; Imazeki, F; Seta, T; Saisho, H
    Roles of TT virus infection in various types of chronic hepatitis
    INTERVIROLOGY
    
    T. Ikeuchi et al., "Roles of TT virus infection in various types of chronic hepatitis", INTERVIROLO, 44(4), 2001, pp. 219-223
80. Ninomiya, T; Yoon, S; Nagano, H; Kumon, Y; Seo, Y; Kasuga, M; Yano, Y; Nakaji, M; Hayashi, Y
    Significance of serum matrix metalloproteinases and their inhibitors on the antifibrogenetic effect of interferon-alfa in chronic hepatitis C patients
    INTERVIROLOGY
    
    T. Ninomiya et al., "Significance of serum matrix metalloproteinases and their inhibitors on the antifibrogenetic effect of interferon-alfa in chronic hepatitis C patients", INTERVIROLO, 44(4), 2001, pp. 227-231
81. Bukh, J; Forns, X; Emerson, SU; Purcell, RH
    Studies of hepatitis C virus in chimpanzees and their importance for vaccine development
    INTERVIROLOGY
    
    J. Bukh et al., "Studies of hepatitis C virus in chimpanzees and their importance for vaccine development", INTERVIROLO, 44(2-3), 2001, pp. 132-142
82. Yamagami, H; Moriyama, M; Tanaka, N; Arakawa, Y
    Detection of serum and intrahepatic human hepatocyte growth factor in patients with type C liver diseases
    INTERVIROLOGY
    
    H. Yamagami et al., "Detection of serum and intrahepatic human hepatocyte growth factor in patients with type C liver diseases", INTERVIROLO, 44(1), 2001, pp. 36-42
83. Ko, JS; Choe, YH; Kim, EJ; Lee, EH; Jang, JJ; Seo, JK
    Interferon-alpha treatment of chronic hepatitis C in children with hemophilia
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
    
    J.S. Ko et al., "Interferon-alpha treatment of chronic hepatitis C in children with hemophilia", J PED GASTR, 32(1), 2001, pp. 41-44
84. Brunt, EM
    Nonalcoholic steatohepatitis: Definition and pathology
    SEMINARS IN LIVER DISEASE
    
    E.M. Brunt, "Nonalcoholic steatohepatitis: Definition and pathology", SEM LIV DIS, 21(1), 2001, pp. 3-16
85. Chitturi, S; Farrell, GC
    Etiopathogenesis of nonalcoholic steatohepatitis
    SEMINARS IN LIVER DISEASE
    
    S. Chitturi e G.C. Farrell, "Etiopathogenesis of nonalcoholic steatohepatitis", SEM LIV DIS, 21(1), 2001, pp. 27-41
86. Baig, NA; Herrine, SK; Rubin, R
    Liver disease and diabetes mellitus
    CLINICS IN LABORATORY MEDICINE
    
    N.A. Baig et al., "Liver disease and diabetes mellitus", CLIN LAB M, 21(1), 2001, pp. 193
87. Seeff, LB; Lindsay, KL; Bacon, BR; Kresina, TF; Hoofnagle, JH
    Complementary and alternative medicine in chronic liver disease
    HEPATOLOGY
    
    L.B. Seeff et al., "Complementary and alternative medicine in chronic liver disease", HEPATOLOGY, 34(3), 2001, pp. 595-603
88. Shimizu, Y; Murata, H; Kashii, Y; Hirano, K; Kunitani, H; Higuchi, K; Watanabe, A
    CC-chemokine receptor 6 and its ligand macrophage inflammatory protein 3 alpha might be involved in the amplification of local necroinflammatory response in the liver
    HEPATOLOGY
    
    Y. Shimizu et al., "CC-chemokine receptor 6 and its ligand macrophage inflammatory protein 3 alpha might be involved in the amplification of local necroinflammatory response in the liver", HEPATOLOGY, 34(2), 2001, pp. 311-319
89. Spinzi, G; Minoli, G
    To biopsy or not to biopsy
    HEPATOLOGY
    
    G. Spinzi e G. Minoli, "To biopsy or not to biopsy", HEPATOLOGY, 34(2), 2001, pp. 438-438
90. Banerjee, S; Owen, C; Chopra, S
    Sickle cell hepatopathy
    HEPATOLOGY
    
    S. Banerjee et al., "Sickle cell hepatopathy", HEPATOLOGY, 33(5), 2001, pp. 1021-1028
91. Sarasin, FP; Majno, PE; Llovet, JM; Bruix, J; Mentha, G; Hadengue, A
    Living donor liver transplantation for early hepatocellular carcinoma: A life-expectancy and cost-effectiveness perspective
    HEPATOLOGY
    
    F.P. Sarasin et al., "Living donor liver transplantation for early hepatocellular carcinoma: A life-expectancy and cost-effectiveness perspective", HEPATOLOGY, 33(5), 2001, pp. 1073-1079
92. Ueno, Y; Moriyama, M; Uchida, T; Arakawa, Y
    Irregular regeneration of hepatocytes is an important factor in the hepatocarcinogenesis of liver disease
    HEPATOLOGY
    
    Y. Ueno et al., "Irregular regeneration of hepatocytes is an important factor in the hepatocarcinogenesis of liver disease", HEPATOLOGY, 33(2), 2001, pp. 357-362
93. Nasti, G; Di Gennaro, G; Tavio, M; Cadorin, L; Tedeschi, RM; Talamini, R; Carbone, A; Tirelli, U
    Chronic hepatitis C in HIV infection: feasibility and sustained efficacy of therapy with interferon alfa-2b and tribavirin
    AIDS
    
    G. Nasti et al., "Chronic hepatitis C in HIV infection: feasibility and sustained efficacy of therapy with interferon alfa-2b and tribavirin", AIDS, 15(14), 2001, pp. 1783-1787
94. Berdowska, A; Zwirska-Korczala, K
    Neopterin measurement in clinical diagnosis
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
    
    A. Berdowska e K. Zwirska-Korczala, "Neopterin measurement in clinical diagnosis", J CLIN PH T, 26(5), 2001, pp. 319-329
95. Langmead, L; Rampton, DS
    Review article: herbal treatment in gastrointestinal and liver disease - benefits and dangers
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    
    L. Langmead e D.S. Rampton, "Review article: herbal treatment in gastrointestinal and liver disease - benefits and dangers", ALIM PHARM, 15(9), 2001, pp. 1239-1252
96. Lefkowitch, JH
    Pathology of the liver
    CURRENT OPINION IN GASTROENTEROLOGY
    
    J.H. Lefkowitch, "Pathology of the liver", CURR OPIN G, 17(3), 2001, pp. 197-204
97. Chokshi, MM; Marrero, JA
    Hepatocellular carcinoma
    CURRENT OPINION IN GASTROENTEROLOGY
    
    M.M. Chokshi e J.A. Marrero, "Hepatocellular carcinoma", CURR OPIN G, 17(3), 2001, pp. 276-280
98. Uno-Furuta, S; Tamaki, S; Takebe, Y; Takamura, S; Kamei, A; Kim, G; Kuromatsu, I; Kaito, M; Adachi, Y; Yasutomi, Y
    Induction of virus-specific cytotoxic T lymphocytes by in vivo electric administration of peptides
    VACCINE
    
    S. Uno-Furuta et al., "Induction of virus-specific cytotoxic T lymphocytes by in vivo electric administration of peptides", VACCINE, 19(15-16), 2001, pp. 2190-2196
99. Bonnet, F; Dubuc, J; Morlat, P; Delbrel, X; Doutre, MS; de Witte, S; Bernard, N; Lacoste, D; Longy-Boursier, M; Beylot, J
    Sarcoidosis and associated illnesses. A 32-case retrospective study
    REVUE DE MEDECINE INTERNE
    
    F. Bonnet et al., "Sarcoidosis and associated illnesses. A 32-case retrospective study", REV MED IN, 22(7), 2001, pp. 619-623
100. Willson, RA
     The benefit of long-term interferon alfa therapy for symptomatic mixed cryoglobulinemia (cutaneous vasculitis/membranoproliferative glomerulonephritis) associated with chronic hepatitis C infection
     JOURNAL OF CLINICAL GASTROENTEROLOGY
     
     R.A. Willson, "The benefit of long-term interferon alfa therapy for symptomatic mixed cryoglobulinemia (cutaneous vasculitis/membranoproliferative glomerulonephritis) associated with chronic hepatitis C infection", J CLIN GAST, 33(2), 2001, pp. 137-140